Correlation Between Zealand Pharma and RTX AS

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Zealand Pharma and RTX AS at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Zealand Pharma and RTX AS into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Zealand Pharma AS and RTX AS, you can compare the effects of market volatilities on Zealand Pharma and RTX AS and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Zealand Pharma with a short position of RTX AS. Check out your portfolio center. Please also check ongoing floating volatility patterns of Zealand Pharma and RTX AS.

Diversification Opportunities for Zealand Pharma and RTX AS

0.61
  Correlation Coefficient

Poor diversification

The 3 months correlation between Zealand and RTX is 0.61. Overlapping area represents the amount of risk that can be diversified away by holding Zealand Pharma AS and RTX AS in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on RTX AS and Zealand Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Zealand Pharma AS are associated (or correlated) with RTX AS. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of RTX AS has no effect on the direction of Zealand Pharma i.e., Zealand Pharma and RTX AS go up and down completely randomly.

Pair Corralation between Zealand Pharma and RTX AS

Assuming the 90 days trading horizon Zealand Pharma AS is expected to generate 1.7 times more return on investment than RTX AS. However, Zealand Pharma is 1.7 times more volatile than RTX AS. It trades about -0.08 of its potential returns per unit of risk. RTX AS is currently generating about -0.23 per unit of risk. If you would invest  88,100  in Zealand Pharma AS on September 3, 2024 and sell it today you would lose (15,100) from holding Zealand Pharma AS or give up 17.14% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Zealand Pharma AS  vs.  RTX AS

 Performance 
       Timeline  
Zealand Pharma AS 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Zealand Pharma AS has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.
RTX AS 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days RTX AS has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Zealand Pharma and RTX AS Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Zealand Pharma and RTX AS

The main advantage of trading using opposite Zealand Pharma and RTX AS positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Zealand Pharma position performs unexpectedly, RTX AS can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in RTX AS will offset losses from the drop in RTX AS's long position.
The idea behind Zealand Pharma AS and RTX AS pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Complementary Tools

Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Commodity Directory
Find actively traded commodities issued by global exchanges
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing